Chemours director granted 7,182 stock units

Chemours Co director Livingston Satterthwaite received an equity award of 7,182 stock units of Chemours common stock as board compensation.

Rhea-AI Filing Summary

Chemours Co director Livingston Satterthwaite received an equity award of 7,182 stock units of Chemours common stock as board compensation. The units were granted at no cash cost to the director and will convert one-for-one into Chemours common shares upon separation from board service.

The award includes deferred stock units and related dividend equivalent units, increasing Satterthwaite’s directly held balance to 30,807.855 shares and stock units combined after this transaction.

Insider Trade Summary

Grant/Award: 7,182 shares

Grant/Award 1 txn

Insider SATTERTHWAITE LIVINGSTON

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,182	$0.00	$0.00

Holdings After Transaction: Common Stock — 30,807.855 shares (Direct)

Footnotes (2)

1. F1. Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board.
2. F2. Includes deferred stock units and dividend equivalent units.

Key Figures

Stock units granted: 7,182 units Grant price per unit: $0.00 per unit Holdings after transaction: 30,807.855 shares/units

3 metrics

Stock units granted 7,182 units Director equity award on May 6, 2026

Grant price per unit $0.00 per unit Reported transaction price for the stock unit award

Holdings after transaction 30,807.855 shares/units Common stock and stock units directly held after the grant

Key Terms

stock units, dividend equivalent units, Grant, award, or other acquisition

3 terms

stock units financial

"Represents stock units that will convert one-for-one to Chemours common stock"

Stock units are individual pieces of ownership in a company, like slices of a pie that together make up the whole business. They matter to investors because each unit represents a claim on the company’s assets, profits and sometimes voting power, and changes in the number or value of these units affect ownership percentages, potential dividends and share dilution — all of which influence an investment’s worth.

dividend equivalent units financial

"Includes deferred stock units and dividend equivalent units."

Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Chemours (CC) director Livingston Satterthwaite report in this Form 4?

Livingston Satterthwaite reported receiving 7,182 Chemours stock units as a grant. These units are board compensation, not an open-market purchase, and increase his directly held balance to 30,807.855 shares and stock units after the transaction.

Was the Chemours (CC) Form 4 transaction a stock purchase or a grant?

The Form 4 shows a grant, coded “A” for award or other acquisition, not a market purchase. Satterthwaite received 7,182 stock units at a reported price of $0.00 per unit as part of director compensation in stock-based form.

How many Chemours (CC) shares and units does Livingston Satterthwaite hold after this grant?

After the reported grant, Satterthwaite directly holds 30,807.855 Chemours common shares and stock units. This figure includes previously deferred stock units, the new 7,182-unit award, and any related dividend equivalent units disclosed in the filing’s footnotes.

What are the stock units granted to the Chemours (CC) director and when do they convert?

The reported award consists of stock units that track Chemours common stock. According to the disclosure, these units will convert one-for-one into Chemours common shares when Satterthwaite separates from service on the board, reflecting typical deferred equity compensation for directors.

Does the Chemours (CC) Form 4 indicate any stock sales or disposals by the director?

No sales or disposals are reported in this Form 4. The filing shows only an acquisition coded as a grant of 7,182 stock units, with no concurrent sales, tax-withholding dispositions, gifts, or restructurings disclosed in the transaction summary data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/08/2026 - 04:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SATTERTHWAITE LIVINGSTON

(Last) (First) (Middle)

C/O THE CHEMOURS COMPANY

1007 MARKET STREET

(Street)

WILMINGTON DELAWARE 19801

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/06/2026		A		7,182(1)	A	$0	30,807.855(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board.

2. Includes deferred stock units and dividend equivalent units.

	/s/ Eric Stein, Attorney-in-Fact	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)